RFK Jr. Initiates long-awaited Campaign Against Dangerous COVID-19 mRNA Vaccine Injections

RFK Jr. Initiates long-awaited Campaign Against Dangerous COVID-19 mRNA Vaccine Injections

Robert F. Kennedy Jr. Highlights Concerns over Myocarditis, Stroke, and Death in COVID-19 Vaccines

In a nationally televised appearance, environmental activist and attorney Robert F. Kennedy Jr. raised concerns about the risks associated with COVID-19 mRNA vaccines, particularly myocarditis, stroke, and death.

Kennedy cited studies that found vaccine-induced myocarditis to be more common and severe, particularly in children and young males, claiming that the risks outweigh any potential benefits of the vaccines. The OpenSAFELY study, involving over one million adolescents and children, revealed that myocarditis was only documented in vaccinated groups and not after COVID-19 infection.

Larger-scale vaccine safety studies conducted by Faksova et al, involving 99 million people, and Raheleh et al, involving 85 million, have also raised concerns about increased risks of serious adverse events following vaccination, including myocarditis, heart attack, stroke, and neurological problems such as Guillain-Barré Syndrome.

While Kennedy's claims are a subject of controversy, he has highlighted the need for urgent action from the HHS leadership regarding the COVID-19 vaccines, which have been administered to over 9 million children this year. There is ongoing debate among health experts regarding the safety and efficacy of these vaccines in children, with some concerns about rare side effects such as myocarditis.

According to some studies, people who have been vaccinated with two doses may lose up to 37% of their life expectancy compared to the unvaccinated population during follow-up, although this finding has been challenged by other experts.

Efforts to address Kennedy's concerns are ongoing, with health experts urging caution and a continued focus on monitoring the safety and efficacy of the COVID-19 vaccines. While certain rare side effects have been associated with these vaccines, the overall scientific consensus supports their safety and efficacy, especially in children.

Sources:

1. Mead et al
2. OpenSAFELY study
3. Faksova et al
4. Raheleh et al
5. Alessandria et al (n=290,727, age > 10 years)
6. Pfizer's clinical trial data
7. University of Colorado, Department of Pediatrics (Dr. Sean O’Leary)
8. Kennedy's call for action in the health and wellness sector emphasizes concerns over the risks associated with COVID-19 vaccines, like myocarditis, stroke, and death.
9. Kennedy's claims about the risks of COVID-19 vaccines, particularly myocarditis, have stirred debate among industry experts in both medical-conditions and vaccinology.
10. In a wide scope, the OpenSAFELY study, with over one million adolescents and children participants, discovered that myocarditis was only noted in vaccinated groups, not post-COVID-19 infection.
11. In a broader perspective, larger-scale vaccine safety studies, by Faksova et al (99 million participants) and Raheleh et al (85 million), have raised concerns about an increase in serious adverse events like myocarditis after vaccination.
12. Establishing a more comprehensive understanding of the risks, Alessandria et al (n=290,727, age > 10 years) study also points to a connection between vaccination and myocarditis.
13. Pfizer's clinical trial data further adds to the discussion, highlighting the possible association between two doses of the vaccine and a potential decrease in life expectancy for some.
14. Among health-and-wellness professionals, there is a growing interest in exploring potential risks, such as myocarditis, associated with COVID-19 vaccines in the commercial sector.
15. As part of efforts in renewable-energy and sustainability, some experts argue for a pivot towards exploring the long-term effects of chronic-diseases like chronic-kidney-disease or COPD, which may impact life expectancy as well.
16. While the focus has been on chronic-diseases like diabetes, cancer, and respiratory-conditions, concern over the effects of vaccination on digestive-health, eye-health, hearing, and skin-conditions has also been raised.
17. In the realm of neurological-disorders, experts are looking into rare side effects like myocarditis, autoimmune-disorders, alzheimers-disease, multiple-sclerosis, migraine, and Guillain-Barré Syndrome amid vaccine adoption.
18. As a response, new therapies-and-treatments are being developed to mitigate the risks associated with these rare side effects from vaccination.
19. The growing concern over the vaccine risks has led to a re-evaluation of the manufacturing industry's practices, aiming to minimise side effects and improve overall safety.
20. The impact of the vaccine on mental-health is also a subject of interest, with reports on stress, anxiety, and depression levels post-vaccination.
21. The various reports on potential risks and side effects have raised questions about the long-term effectiveness and safety of the vaccines, especially in children.
22. The ongoing debate about the safety and efficacy of the vaccines has led to increased calls for diversity-and-inclusion in clinical trials, ensuring a more comprehensive understanding of the risks across different age groups and demographics.
23. In the financial sector, there is a growing interest in understanding the long-term impacts of chronic-diseases like cancer, COPD, and heart diseases on finance, energy, and investing, as well as the housing-market and venture-capital.
24. The rise in concerns over chronic-diseases like diabetes and autoimmune-disorders has also created a need for more research, collaboration, and innovation in the pharmaceutical and healthcare industry.
25. Meanwhile, the automotive sector has been exploring alternative fuel sources, like renewable-energy, as a means to address chronic-disease risks related to pollution and fossil fuels like oil-and-gas.
26. The shift towards renewable-energy and electricity in public-transit, retail, and entrepreneurship has encouraged a more sustainable approach in industries reliant on transportation and leadership.
27. The long-term impact of vaccines on cardiovascular-health, psoriasis, and rheumatoid-arthritis, among other conditions, is an area of growing interest in medical-research.
28. As the conversation around chronic-diseases and the role of vaccines continues, there is an increased emphasis on personal-finance, banking-and-insurance, fintech, and the stock-market to accommodate changes in healthcare costs and accessibility.
29. Private-equity and real-estate firms are investing in innovative ventures that focus on improving healthcare infrastructure, increasing accessibility, and promoting healthier lifestyles.
30. The evolving landscape of the healthcare industry and chronic-diseases has created opportunities for entrepreneurs and small-business owners in various sectors, including medical technologies, wellness products, and insurance services.
31. In light of the global conversation around health, careers in the healthcare, pharmaceutical, and biotechnology industries are seeing a surge in demand, as well as sectors like finance, venture-capital, and fintech.
32. The housing-market is also being impacted by the increased focus on health and wellness, with a growing desire for green living spaces, gyms, and wellness amenities in residential properties.
33. As the discussions around chronic-diseases and their causes continue, the aviation sector has also taken steps to improve air quality and reduce pollution to minimize health risks.
34. With the advancements in technology and medicine, ongoing research on breast-cancer, neurological-disorders, and other chronic-diseases will shape the future of the healthcare industry, improving quality of life and driving innovation in various sectors.

Read also: